Osteoporosis clinical trials
Other conditions
By location or age: Massachusetts
183 trials are recruiting, according to ClinicalTrials.gov.
Showing 100 of 183, newest first. Checked against the registry on 22 November 2026. Listing a trial here is not a recommendation; taking part is voluntary and each study team decides who is eligible.
Synbiotic to Attenuate Resorption of the Skeleton
Ages 60 Years to no maximum · 1 site · Hebrew SeniorLife
Details and how to check if you qualify · NCT06389539 on ClinicalTrials.gov
Fighting Osteoporosis With Risedronate Co-Therapy During Incretin
Ages 60 Years to no maximum · 1 site · Wake Forest University Health Sciences
Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD
Ages 60 Years to no maximum · 9 sites · Sahlgrenska University Hospital
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Ages 18 Years to 100 Years · 1 site · Bettina Mittendorfer
Romosozumab and Denosumab Combination Therapy for Osteoporosis
Ages 45 Years to no maximum · 0 sites · Massachusetts General Hospital
Quanduzhong Capsules for Primary Osteoporosis
Ages 18 Years to 75 Years · 3 sites · Shanghai University of Traditional Chinese Medicine
Post-osteoporotic Fracture Exercise Program
Ages 18 Years to no maximum · 1 site · Western University, Canada
Exercise and Fall Prevention for Fracture Reduction
Ages 65 Years to no maximum · 1 site · Wolfgang Kemmler, PhD
Study of TST002 Injection in Postmenopausal Women With Osteoporosis or Low Bone Mass
Ages 45 Years to 80 Years · 0 sites · Transcenta Therapeutics (Hangzhou) Co., Ltd.
Bone Deterioration After Kidney Transplantation Assessed by DXA and HR-pQCT
Ages 18 Years to no maximum · 1 site · Medical University Innsbruck
Effects of Sensorimotor Balance Training vs Digitally Augmented Core Stabilization in Women With Osteoporosis
Ages 45 Years to 70 Years · 1 site · Riphah International University
A Clinical Study to Collect Real-wordt Data on Safety and Clinical Performance of the VCFix Spinal System for Treatment of Vertebral Compression Fractures of (Suspected) Osteoporotic Origin.
Ages 21 Years to 85 Years · 3 sites · Amber Implants B.V.
Osteoporosis & Renal Disease: Research in Primary Health Care Services
Ages 40 Years to 90 Years · 1 site · Universidade do Porto
Controlled Reduction of AO Spine B3 Fractures in Ankylosing Spinal Disorders Using an Inflatable Positioning Device: Technical Note and Retrospective Single-centre Case Series
Ages 18 Years to no maximum · 0 sites · Diakonie-Klinikum Stuttgart
Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Clinical Trial at 6 Years
Ages 18 Years to no maximum · 1 site · Tuen Mun Hospital
Full-Spectrum Cannabis Extract for Chronic Pain and Bone Health Biomarkers in Women
Ages 45 Years to 80 Years · 1 site · Associação Pan-Americana Multidisciplinar de Endocanabinologia
EFFECTIVENESS AND CLINICAL OPTIMIZATION OF A STANDARDIZED PHYSIOTHERAPY EXERCISE PROGRAM TARGETING BALANCE-POSTURE INTERACTION AND FALL RISK IN OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIAL
Ages 50 Years to no maximum · 1 site · Alma Mater Europaea - Slovenia
Calcium-Rich Food Versus Calcium Carbonate for Bone Health
Ages 40 Years to 90 Years · 1 site · Cornell University
Effect of Postural Correction Exercises on Pelvic Floor Dysfunction in Postmenopausal Osteoporotic Women
Ages 55 Years to 65 Years · 1 site · Cairo University
GRACE II (General Retrospective Analysis of Commercial Experience With AGN1 LOEP)
Ages No minimum to no maximum · 1 site · AgNovos Healthcare, LLC
The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation
Ages 50 Years to 85 Years · 1 site · National Taiwan University Hospital
The Relationship Between Lipedema and Osteoporosis
Ages 18 Years to no maximum · 0 sites · Fatih Sultan Mehmet Training and Research Hospital
A Study of Romosozumab in People With Breast Cancer and Osteoporosis
Ages 18 Years to no maximum · 7 sites · Memorial Sloan Kettering Cancer Center
Pharmacokinetics of Zoledronic Acid in Patients on Dialysis
Ages 18 Years to no maximum · 1 site · University of Campinas, Brazil
High-Intensity Laser Therapy and Physiotherapy for Bone Health in Postmenopausal Women: A Randomized Trial
Ages 50 Years to 70 Years · 1 site · Iuliu Hatieganu University of Medicine and Pharmacy
Osteoporotic Fracture and Lidocaine Plaster 5% for Neuropathic Pain preventioN
Ages 50 Years to no maximum · 1 site · University Hospital, Clermont-Ferrand
Link Between ASCorbemia Level and Osteoporosis
Ages 50 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Nice
Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females
Ages 45 Years to 70 Years · 1 site · University of Connecticut
Clinical Study on a New Diagnostic Strategy for Osteoporosis and Sarcopenia in Chronic Kidney Disease Patients Based on MRI-FF
Ages 18 Years to 80 Years · 1 site · Capital Medical University
REMS vs DXA for Osteoporosis Diagnosis and Fracture Risk Prediction
Ages 30 Years to 90 Years · 2 sites · BoneVue Diagnostics
The Effect of Osteoporotic Medications on Vertebral Bone Quality Score
Ages 50 Years to no maximum · 1 site · State University of New York at Buffalo
Osteoporosis and Sarcopenia Prevention in Middle-Aged Population
Ages 40 Years to 60 Years · 1 site · The University of Hong Kong
Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery for FFP3-4 Fragility Fractures of the Pelvis in Elderly Patients
Ages 60 Years to no maximum · 1 site · Junbo Liang
A Retrospective and Prospective Clinical Registry for Data Collection of Perimenopausal, Menopausal and Premature Ovarian Insufficiency Women
Ages 18 Years to 65 Years · 0 sites · IRCCS San Raffaele
Contribution of Bone to Urine Citrate
Ages 18 Years to no maximum · 1 site · University of Texas Southwestern Medical Center
Can Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women?
Ages 45 Years to no maximum · 1 site · Kanuni Sultan Suleyman Training and Research Hospital
People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk
Ages 70 Years to no maximum · 1 site · McGill University Health Centre/Research Institute of the McGill University Health Centre
Functional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study
Ages 18 Years to no maximum · 1 site · Kanuni Sultan Suleyman Training and Research Hospital
A Phase II Clinical Trial of the Safety and Efficacy of SAL056 at Different Doses and Dosing Regimens
Ages 45 Years to 80 Years · 1 site · Shenzhen Salubris Pharmaceuticals Co., Ltd.
U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures
Ages 22 Years to no maximum · 3 sites · Precision IO Group
OSTEOPOROSIS EDUCATION AND ITS IMPACT ON OSTEOPOROSIS HEALTH BELIEFS AND AWARENESS IN WOMEN AT RISK OF OSTEOPOROSIS
Ages 45 Years to 80 Years · 1 site · Bartın Unıversity
Comparing Implant Retention Versus Removal for MRONJ at Implant Sites
Ages 20 Years to no maximum · 1 site · Kyunghee University Dental Hospital
Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength
Ages 50 Years to 65 Years · 0 sites · Kanuni Sultan Suleyman Training and Research Hospital
Study in Patients With Osteoporosis and Fragility Fractures to Estimate the Extent and Impact of Delayed Administration of Anti-fracture Therapy
Ages 18 Years to no maximum · 1 site · Azienda Ospedaliero, Universitaria Pisana
Self-questionnaire in Osteoporosis
Ages 18 Years to no maximum · 1 site · CHU de Quebec-Universite Laval
Food Trial Evaluating Fecal Abundance of SBD111 With Once-Daily Versus Twice-Daily Administration in Healthy Adults
Ages 35 Years to no maximum · 0 sites · Solarea Bio, Inc
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
Ages 50 Years to no maximum · 15 sites · AO Foundation, AO Spine
Artificial Intelligence-Guided Diagnosis for High-Risk Osteoporosis Populations: A Pragmatic Randomized Clinical Trial
Ages 40 Years to 80 Years · 3 sites · Taichung Veterans General Hospital
Radiographic Cortical Thickness of the Humerus in Detecting Post-Stroke Regional Bone Loss
Ages 18 Years to no maximum · 1 site · Istanbul Physical Medicine Rehabilitation Training and Research Hospital
A Study Evaluating the Performance of Using AI Software and Chest X-rays to Screen for Osteoporosis as Compared to Standard DXA Scans in Patients 50 Years and Older
Ages 50 Years to no maximum · 3 sites · Promedius Inc
Female Osteoporosis
Ages 50 Years to 75 Years · 0 sites · Kayseri City Hospital
Comparison of Bone Microarchitecture Analysed by HRpQCT and pQCT in Pathologies With Bone Loss and/or Muscle Loss
Ages 18 Years to no maximum · 1 site · Centre Hospitalier Universitaire de Saint Etienne
Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes
Ages 50 Years to no maximum · 4 sites · Peking Union Medical College Hospital
Evaluation of Dora Care for Supporting Fracture Liaison Services (FLS)
Ages 50 Years to no maximum · 0 sites · Ufonia
Patient Education in Osteoporosis (RCT-PATOS)
Ages 50 Years to no maximum · 7 sites · University Hospital, Linkoeping
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
Ages 65 Years to no maximum · 2 sites · Brigham and Women's Hospital
AGE Burden and Response to Antiresorptive Therapy in Osteoporosis
Ages 50 Years to no maximum · 0 sites · Bursa City Hospital
Effect of Biofeedback Activation on Balance in Osteoporotic Elderly
Ages 65 Years to 75 Years · 1 site · Mohamed Said Alsafy Alhamrawy
Bone Health in Postmenopausal Women: The Effect of Exercise With or Without Medication for Osteoporosis
Ages 55 Years to 75 Years · 1 site · Loughborough University
Step-down Therapy After Long-term Osteoporosis Treatment
Ages 50 Years to 85 Years · 1 site · National Taiwan University Hospital
Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders
Ages 18 Years to 90 Years · 1 site · Martin Blomberg Jensen
Comparison of Bone Mineral Density in the Third Trimester Between Women in Singleton and Twin Pregnancies Using Questionnaires and REMS Densitometric Examination
Ages 30 Years to 45 Years · 1 site · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Prunes Preventing Bone Loss in Perimenopause
Ages 44 Years to 55 Years · 1 site · Penn State University
Assessment and Comparison of Osteoporosis Risk Factors After Stroke
Ages 55 Years to 85 Years · 1 site · Ankara Etlik City Hospital
REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)
Ages 5 Years to 18 Years · 1 site · Meyer Children's Hospital IRCCS
Romosozumab and Denosumab, Alone or Combined, in Postmenopausal Osteoporosis
Ages 50 Years to 80 Years · 1 site · National Taiwan University Hospital
The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients
Ages 40 Years to 65 Years · 1 site · Kirsehir Ahi Evran Universitesi
Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship
Ages 18 Years to 65 Years · 1 site · Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Vitamin D Status and Multi-Omics Profiles in Primary Osteoporosis
Ages 18 Years to no maximum · 1 site · Dr. Li Chen
A Clinical Study Evaluating the Safety and Efficacy of the VCFix Spinal System for Treatment of Vertebral Compression Fractures
Ages 21 Years to 85 Years · 3 sites · Amber Implants B.V.
Chiropractor Delivered Virtual Intervention After Vertebral frActure
Ages 50 Years to no maximum · 1 site · University of Waterloo
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
Ages 60 Years to 75 Years · 2 sites · Odense University Hospital
Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects
Ages 18 Years to 45 Years · 1 site · Shenzhen Salubris Pharmaceuticals Co., Ltd.
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Ages 18 Years to no maximum · 27 sites · Blueprint Medicines Corporation
GLP-1R Actions on Muscle and the Skeleton
Ages 18 Years to 50 Years · 1 site · Pennington Biomedical Research Center
StrAtegies For Zoledronic Acid Post-dEnosumab Discontinuation in Postmenopausal oSTeoporosis
Ages 18 Years to no maximum · 17 sites · University Hospital, Toulouse
COMPASS - COpenhagen MenoPAuSe Study
Ages 40 Years to 65 Years · 1 site · Martin Blomberg Jensen
Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis
Ages 35 Years to 70 Years · 2 sites · Regina Elena Cancer Institute
The Effect of Semaglutide on Bone Health
Ages 50 Years to 75 Years · 1 site · The First Affiliated Hospital of Xiamen University
Resting-state Imaging and OSteoporosiS
Ages 50 Years to no maximum · 1 site · University Hospital, Clermont-Ferrand
Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Osteoporosis (DHEAL-COM-OP)
Ages 65 Years to no maximum · 1 site · Istituto Nazionale di Ricovero e Cura per Anziani
25(OH)-Vitamin D and Its Association With Structural and Functional Parameters in Hospitalized Patients With Neurological Diseases
Ages 20 Years to 85 Years · 2 sites · Dionyssiotis, Yannis, M.D.
MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis
Ages 50 Years to no maximum · 2 sites · Istituto Auxologico Italiano
Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis
Ages 18 Years to no maximum · 1 site · Peter Humaidan
A Clinical Study Evaluating the Dermal Safety of Soluble Denosumab Microneedle Patches
Ages 18 Years to 70 Years · 1 site · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Health Literacy and Osteoporosis Awareness
Ages 65 Years to no maximum · 1 site · Bandırma Onyedi Eylül University
Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge
Ages 50 Years to no maximum · 0 sites · SingHealth Polyclinics
A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®
Ages 50 Years to 85 Years · 1 site · Qilu Pharmaceutical Co., Ltd.
The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60
Ages 50 Years to 59 Years · 0 sites · Beylikduzu State Hospital
The Oswestry Metabolic BONE Cohort
Ages 18 Years to no maximum · 1 site · Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture
Ages 50 Years to 85 Years · 0 sites · Qilu Pharmaceutical Co., Ltd.
Dairy vs Plant-based Beverages for Improving Bone Health During Exercise
Ages No minimum to no maximum · 1 site · University of Saskatchewan
Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis
Ages 60 Years to 70 Years · 0 sites · Peking University Third Hospital
Orthorexia Nervosa in Postmenopausal Osteoporosis
Ages 55 Years to 75 Years · 1 site · Beylikduzu State Hospital
Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
Ages 50 Years to 90 Years · 1 site · National Taiwan University Hospital
Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid.
Ages 50 Years to no maximum · 1 site · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients
Ages 20 Years to 70 Years · 1 site · Grigore T. Popa University of Medicine and Pharmacy
Holistic Integration for Healthy Longevity and Aging in Place
Ages 55 Years to no maximum · 0 sites · National Taiwan University Hospital
A Study of Amorphous Calcium Carbonate in Postmenopausal Women
Ages 60 Years to 90 Years · 1 site · Universal Integrated Corp.
Periprosthetic Plate Over Humeral Nail
Ages 16 Years to 40 Years · 0 sites · Assiut University
More: Acne clinical trials · Alzheimer’s disease and related dementias clinical trials · Cannabis use disorder clinical trials · Chronic hives (chronic urticaria) clinical trials · COPD (chronic obstructive pulmonary disease) clinical trials · Depression clinical trials · Depression (major depressive disorder) clinical trials · Moderately to severely active crohn's disease clinical trials · Rett syndrome clinical trials